These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17443289)

  • 1. Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival.
    Peria FM; Neder L; Marie SK; Rosemberg S; Oba-Shinjo SM; Colli BO; Gabbai AA; Malheiros SM; Zago MA; Panepucci RA; Moreira-Filho CA; Okamoto OK; Carlotti CG
    J Neurooncol; 2007 Sep; 84(3):255-61. PubMed ID: 17443289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
    Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
    Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas.
    Ulbricht U; Brockmann MA; Aigner A; Eckerich C; Müller S; Fillbrandt R; Westphal M; Lamszus K
    J Neuropathol Exp Neurol; 2003 Dec; 62(12):1265-75. PubMed ID: 14692702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher YAP1 Levels Are Associated With Shorter Survival of Patients With Low Grade Astrocytoma.
    Dicke J; Hero L; Kuhl S; Görtz L; Goldbrunner R; Timmer M
    Anticancer Res; 2024 Jul; 44(7):3005-3011. PubMed ID: 38925840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nogo-A expression in oligodendroglial tumors.
    Jung TY; Jung S; Lee KH; Cao VT; Jin SG; Moon KS; Kim IY; Kang SS; Kim HS; Lee MC
    Neuropathology; 2011 Feb; 31(1):11-9. PubMed ID: 20487307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients.
    Smith SF; Simpson JM; Brewer JA; Sekhon LH; Biggs MT; Cook RJ; Little NS
    J Neurooncol; 2006 Oct; 80(1):75-82. PubMed ID: 16794749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
    Heesters MA; Koudstaal J; Go KG; Molenaar WM
    J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvessel density in brain tumors.
    Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
    Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features in the recurrence of oligodendroglioma and diffuse astrocytoma.
    Takeuchi H; Hosoda T; Kitai R; Kodera T; Arishima H; Tsunetoshi K; Neishi H; Yamauchi T; Sato K; Imamura Y; Itoh H; Kubota T; Kikuta K
    Brain Tumor Pathol; 2012 Jul; 29(3):140-7. PubMed ID: 22648019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profile of tumors with oligodendroglial morphology: Clinical relevance.
    Geevar T; Pai R; Chacko G; Malepathi K; Patel B; John J; Chacko AG; Balakrishnan R; John S
    Neurol India; 2018; 66(6):1726-1731. PubMed ID: 30504574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.
    Kim CH; Bak KH; Kim YS; Kim JM; Ko Y; Oh SJ; Kim KM; Hong EK
    Surg Neurol; 2000 Sep; 54(3):235-40. PubMed ID: 11118570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
    Erdamar S; Bagci P; Oz B; Dirican A
    J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha(v)beta(3) Integrin in central nervous system tumors.
    Lim M; Guccione S; Haddix T; Sims L; Cheshier S; Chu P; Vogel H; Harsh G
    Hum Pathol; 2005 Jun; 36(6):665-9. PubMed ID: 16021573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase related protein expression in astrocytomas and oligodendroglial tumors.
    Karjalainen SL; Haapasalo HK; Aspatwar A; Barker H; Parkkila S; Haapasalo JA
    BMC Cancer; 2018 May; 18(1):584. PubMed ID: 29792187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
    Neuropathology; ; . PubMed ID: 16193836
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.